Rentschler Biopharma SE, a global contract development and manufacturing organisation (CDMO) specialising in biopharmaceuticals, has announced the construction of a new buffer media station at its headquarters in Laupheim, Germany. The new, four-storey facility, covering 34,000 square metres, is designed
Rentschler Biopharma SE, a global CDMO specializing in biopharmaceuticals and advanced therapy medicinal products (ATMPs), has announced the launch of expanded services at its Stevenage, UK site. The new service offering introduces a lentiviral vector (LVV) manufacturing toolbox, enhancing the
Rentschler Biopharma SE has announced the full operational status of its new production line in Milford, Massachusetts. This expansion, the largest in the company’s history, doubles its global capacity to meet the increasing demand for biopharmaceuticals aimed at treating rare
